Skip to content

Tenofovir Anhydrous

  • Prescription medicine
  • Prescription only
  • Identity checked
  • Sources last checked 2026-09-04

This page shows what was measured, who it was measured in, and what that does not settle.

What Tenofovir Anhydrous does in the body

Tenofovir disoproxil fumarate tablets are a nucleotide analog HIV-1 reverse transcriptase inhibitor and an HBV reverse transcriptase inhibitor. • Tenofovir disoproxil fumarate tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 2 years of age and older.

Tenofovir disoproxil fumarate is an antiviral drug [See Microbiology ( 12.4 )].

Why people take it. Tenofovir disoproxil fumarate tablets are a nucleotide analog HIV-1 reverse transcriptase inhibitor and an HBV reverse transcriptase inhibitor. • Tenofovir disoproxil fumarate tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 2 years of age and older.

What happened in people

RNAWiki has not yet published a reviewed conclusion for this use.

A fixed RNAWiki sentence

Where this came from

Wording RNAWiki always uses, not a finding about this substance.

No reviewed claim names a result for any goal on this record.

No source is stored against this line.

The limit that matters most

Not recorded.

Where it acts
Not recorded.
Kind of result
No result is published, so no kind of result applies yet
Supervision
RNAWiki has not recorded a supervision or regulatory status for this substance.

What the registries record it as

  • Its recorded molecular formula is C9H14N5O4P, weighing 287.21.

    PubChem record · 464205 · read 2026-08-29

Where each sentence above came from

The use the label states, quoted from it. No plain-language version of this sentence has been written.

The use the label states, quoted from it. It is written for a clinician, not for a reader without medical training.

No statement of the main limit is recorded.

The four opening statements run to 116 words.

Words this page uses

Four words worth knowing first

Chosen from what this page shows, with each one explained before the word it depends on.

Biomarker

A biomarker is a number from a test that stands in for something about health.

A picture of it, and where the picture fails

A biomarker is like a fuel gauge.

Where that stops being true. A gauge is wired to the tank. Many biomarkers are only loosely tied to health.

What people get wrong. A better number is read as a better life. Several medicines improved a number and helped nobody.

A measurable indicator used as a substitute for a clinical outcome of interest.

Placebo

A placebo is a dummy treatment given so the real one can be compared with it.

A picture of it, and where the picture fails

A placebo is like a blank control in an experiment.

Where that stops being true. A blank does nothing. People given a placebo often do get better.

What people get wrong. A placebo effect is read as imaginary. The improvement is measured and real.

An inactive intervention matched in appearance to the test intervention, used to control for non-specific effects.

Comparator

A comparator is whatever the treatment was measured against.

A picture of it, and where the picture fails

It is like the other runner in a race.

Where that stops being true. A race has one winner. A study can show both arms improved.

What people get wrong. Results are read without asking what the other group got. Beating nothing is not beating a treatment.

The control condition against which the experimental intervention is assessed.

What happened in peopleRead from sources, not yet reviewed

What happened in people

Each card is one study: the exact question it asked, who was in it, and whether it showed what it set out to show.

Difference in neonatal mortality rate between intervention and control periods

The study did not show it

Who was studied
NCT07126041
How many people
1750000
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
Living longer, or avoiding a major event
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot

Uptake of initial and repeat HIV counselling and testing (Feasibility phase)

The study did not show it

Who was studied
NCT01509508
How many people
28153
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot

Proportion of women accessing family planning services who are screened for HIV risk

The study did not show it

Who was studied
NCT04666792
How many people
25457
Study design
Phase 4
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot

Incidence of HIV infection per 100 person years among study participants

The study did not show it

Who was studied
NCT02870790
How many people
9733
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot

HBsAg Screening Uptake

The study did not show it

Who was studied
NCT07258251
How many people
6000
Study design
Phase 4
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot

PreP uptake

The study did not show it

Who was studied
NCT06743204
How many people
5560
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot
What we know
RNAWiki holds 6 written-up human studies for this substance, each with the question it asked.
How we know it
Each card names the study, the number of people and what the study set out to measure.
What this does not prove
These summaries were written by a person and have not been signed off as reviewed claims.
Why it matters
A study that failed is as informative as one that worked, and both are here.
What we still do not know
No reviewed claim exists, so no exact population, effect size or interval is published yet.

What is missing or unclearRead from sources, not yet reviewed

Were people like you studied?

RNAWiki cannot tell whether a study fits you. It can show who was in it, and where the result stops carrying.

Who was studied

No description of who was studied is recorded.

Who is missing from the studies

  • Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

What the label states about particular groups

  • On pediatric, the label states: “Five additional subjects over the age of 12 were enrolled and randomized (tenofovir disoproxil fumarate tablets N=4, original regimen N=1) but are not included in the efficacy analysis.”

    US prescribing information · 08a30772-02fc-4f63-e063-6394a90afd43 · read 2026-09-12

  • On older people, the label states: “Clinical trials of tenofovir disoproxil fumarate tablets did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.”

    US prescribing information · 08a30772-02fc-4f63-e063-6394a90afd43 · read 2026-09-12

  • On people who are pregnant, the label states: “Category B There are no adequate and well-controlled studies in pregnant women.”

    US prescribing information · 08a30772-02fc-4f63-e063-6394a90afd43 · read 2026-09-12

  • On people who are breastfeeding, the label states: “The Centers for Disease Control and Prevention recommend that HIV-1 infected mothers not breastfeed their infants to avoid risking postnatal transmission of HIV-1.”

    US prescribing information · 08a30772-02fc-4f63-e063-6394a90afd43 · read 2026-09-12

Where the result stopped carrying

  • This is a scope explorer, not a diagnosis engine.
  • It shows who was studied so you can see whether people similar to you were included.

RNAWiki cannot tell whether a study fits you. It can show who was in it.

What it would be like to takeRead from sources, not yet reviewed

Why it might seem to do nothing

A real effect and a noticed effect are different things. These are the recorded reasons the two come apart.

It was studied in different people

The people in the studies were not much like the reader.

On this record: Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

The evidence may simply be wrong

Small early studies often do not hold up.

On this record: RNAWiki has not yet published a reviewed conclusion for this use.

Other reasons RNAWiki checked and found nothing for (11)
It was studied for a different goal
The studies measured something else entirely. Nothing in this record points to this reason.
A different form was studied
The studied form is not the form on the shelf. Nothing in this record points to this reason.
There was nothing to correct
Where a level is already normal, topping it up may change nothing. Nothing in this record points to this reason.
Something else had to happen too
In the studies it was paired with training, a diet or another treatment. Nothing in this record points to this reason.
The change is too small to feel
A real change can still sit below what a person notices. Nothing in this record points to this reason.
Day-to-day swing hides it
Sleep, food, stress and time of day move most numbers more than this would. Nothing in this record points to this reason.
Not enough time yet
The studies ran longer than the person has waited. Nothing in this record points to this reason.
It was not taken as studied
Missed days change the result, and studies count them. Nothing in this record points to this reason.
Something else changed at the same time
Two changes at once cannot be told apart afterwards. Nothing in this record points to this reason.
The product may not be what it says
Contents of a sold product are not always what the label states. Nothing in this record points to this reason.
No recorded reason
RNAWiki has nothing stored that would explain it. Nothing in this record points to this reason.

None of these is a reason to take more. Taking more is not a step this page ever suggests.

What it would be like to takeRead from sources, not yet reviewed

What taking it involves

The recorded facts about getting hold of it and using it. Nothing here is a suggestion about what you should do.

How it is supplied

Prescription only

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

Read from the recorded approval status.

No source is stored against this line.

Form and route

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

No form or route is recorded.

No source is stored against this line.

Who oversees it

RNAWiki has not recorded a supervision or regulatory status for this substance.

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

No register row and no identity class settled the question.

No source is stored against this line.

What is in the pack

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

Nothing is recorded about product quality.

No source is stored against this line.

Where it is registered

Regulatory records are listed in the technical disclosure at the foot of this page.

Counted from records

Where this came from

A count of rows RNAWiki holds. It describes our records, not your body.

Register entries are stored per jurisdiction and shown with their dates.

No source is stored against this line.

Why people stop

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

No record of why people stopped taking it is stored for this substance.

No source is stored against this line.

What it would be like to takeNothing found in the sources checked

What can go wrong

Sorted by where each line came from. A regulator's label and a report somebody sent in are not the same kind of fact.

Nothing found in the sources checked

No harm is recorded against this substance in the sources RNAWiki checked. Finding nothing is not the same as showing there is nothing.

The sources listed were searched and held nothing. That is not the same as nothing existing.

Over a long time. No completed tested study window is recorded, so long-term effects are not established by the registry record.

Groups the studies covered thinly. Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

What is missing or unclearRead from sources, not yet reviewed

Does the exact form matter?

Evidence belongs to the exact thing that was tested. A different salt, a different mixture or a different preparation is a different question.

The form that was studied

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

The exact form studied is not recorded.

No source is stored against this line.

What is sold

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

Nothing further is recorded about which forms are sold.

No source is stored against this line.

What is recorded as being sold

  • Tenofovir Disoproxil Fumarate is oral at 3 DOSAGE FORMS & STRENGTHS Tenofovir disoproxil fumarate is available as tablets., recorded as fda label in effect 2025-10-09 in the United States.

    US prescribing information · 08a30772-02fc-4f63-e063-6394a90afd43 · read 2026-09-12

Evidence carries across two names for one substance. It does not carry across a salt, a mirror form or a mixture.

What it would be like to takeRead from sources, not yet reviewed

What you could measure

This one is decided with a clinician, so this section holds questions to ask rather than a plan to run.

RNAWiki could not confidently classify this substance, so no self-experiment plan is offered.

Questions worth asking

  • Which of the trials of Tenofovir Anhydrous studied people like me?
  • What was measured, and for how long?
  • Was the result a laboratory value or a health outcome?
  • What would we watch for, and when would we stop?

Tracking can show whether something changed for you. It cannot show what caused it.

RNAWiki records evidence. It does not say whether this substance is right for you.

What is missing or unclearRead from sources, not yet reviewed

What nobody knows yet

Open questions, each with why it is open and what would close it.

Missing populations

Which groups were under-represented in the studies has not been recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing long-term data

No completed tested study window is recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

No reviewed conclusion

RNAWiki has not yet published a reviewed conclusion for this use.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing interaction studies

No interaction was found in the registers checked. Not finding one is not the same as showing there is none.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Formulation uncertainty

Several salts, forms or products of Tenofovir Anhydrous are recorded. Results from one form may not transfer to another.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Mechanism not reviewed

No reviewed mechanism story exists for this substance.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

What happened in peopleNothing found in the sources checked

Check any of this yourself

Every line above traced back to the study it came from. This is the technical layer, and the vocabulary changes here.

Nothing found in the sources checked

No traced study record is stored for this substance.

The sources listed were searched and held nothing. That is not the same as nothing existing.

Checks this page had to pass

  • Passed

    Identity resolved

    no open identity hold

  • Passed

    No unresolved merge across substance families

    no quarantine open

  • Passed

    Every public sentence names a source

    The opening statement carries the origin: Quoted from a stored source.

  • Not passed

    Trial roles classified for highlighted evidence

    No registered study is classified as testing this substance.

  • Passed

    No internal keys in reader text

    enforced by the copy-contract test over the rendered page

  • Not passed

    Safety mode resolved

    No register row and no identity class settled the question.

  • Passed

    Canonical metadata present

    slug and display name present

What is missing or unclearRead from sources, not yet reviewed

How this medicine reached us

Kept near the foot of the page. A historical event moves up only when it changes something about this substance today.

What the approval register records

  • 1 approved application covers products containing this substance.

    Drugs@FDA application register · NDA022459 · read 2026-08-29

  • Marketing status on the register: none (tentative approval).

    Drugs@FDA application register · NDA022459 · read 2026-08-29

What is missing or unclearRead from sources, not yet reviewed

What to learn next

Ordered by what would most change how you read this page, starting with what is easiest to misunderstand.

This order is fixed in code and does not count clicks or time on the page.

What is not here

9 questions this page could not answer

These sections were prepared and left out because there was nothing to put in them. They are listed rather than hidden, so the gaps in this record are visible.

  • What was measured, goal by goal — found nothing in the sources checked.
  • How close this is to real life — found nothing in the sources checked.
  • The path through the body — found nothing in the sources checked.
  • Felt, measured, or meaningful — found nothing in the sources checked.
  • How long anything takes — found nothing in the sources checked.
  • What it may clash with — found nothing in the sources checked.
  • Other ways to the same goal — found nothing in the sources checked.
  • Claims that go past the evidence — found nothing in the sources checked.
  • What changed on this page — found nothing in the sources checked.

The record as stored

The full record, for auditing

Everything above is built from what is below. This layer keeps the technical vocabulary, record identifiers and every stored row, so a reader who wants to check the page can.

Recorded evidence blocks (7)

281 registered trials of Tenofovir Anhydrous — at which phases?


Registered studies posting no result
209 of 281

281 registered studies of Tenofovir Anhydrous: 69 phase2, 67 phase4, 46 phase3, 41 phase1, 35 na or unstated, 31 na, 3 early phase1. CLINICALTRIALS_SNAPSHOT · 2026-09-01

1565 with a PubMed record

Show the evidence
  • phase2
    69
  • phase4
    67
  • phase3
    46
  • phase1
    41
  • na or unstated
    35
  • na
    31
11 more recorded rows
  • early phase1
    3
  • completed
    177
  • unknown
    49
  • terminated
    25
  • withdrawn
    9
  • recruiting
    8
  • active not recruiting
    6
  • not yet recruiting
    3
  • enrolling by invitation
    2
  • approved for marketing
    1
  • no longer available
    1

recorded 2026-09-01 · last checked 2026-09-04

25 of Tenofovir Anhydrous's trials stopped: safety, accrual/recruitment, funding/business, sponsor decision unspecified, other?


safety (4), accrual/recruitment (7), funding/business (9), sponsor decision unspecified (2) and other (3): Tenofovir Anhydrous's stop wording, clustered. CLINICALTRIALS_SNAPSHOT · 2026-09-01

"study was withdrawn before any participants were recruited and enrolled"; 25 of 281 registered studies

Show the evidence

Trial

  • NCT00087464
    withdrawn; "study was withdrawn before any participants were recruited and enrolled"
  • NCT00409019
    withdrawn; "Study cancelled: Withdrawn before enrollment of any participants"
  • NCT00998582
    terminated; "Low enrollment"
  • NCT01260610
    withdrawn; "lack of funds"
  • NCT01528865
    withdrawn; "Funding was removed."
  • NCT01601899
    terminated; "DSMB decision to begin closeout process in view of April 2010 SA HAART guideline"
14 further recorded trials
  • NCT01614405
    terminated; "Protracted gastrointestinal symptoms were experienced by most patients who were subsequently found to be in the treatment arm on LPV/r. This observation resulted in cessation of enrolment and a decision not to continue the RCT"
  • NCT01872988
    terminated; "Difficult in patient enrollment"
  • NCT02116660
    terminated; "This study was terminated early due to poor recruitment."
  • NCT02322099
    terminated; "Due to the COVID-19 pandemic the study was terminated prematurely"
  • NCT02386098
    terminated; "GI Intolerability"
  • NCT02452528
    terminated; "Company decision to discontinue trial"
  • NCT02454764
    withdrawn; "lack of funds"
  • NCT02577029
    terminated; "Company decision to discontinue trial"
  • NCT02604199
    terminated; "Company decision to discontinue trial"
  • NCT02604212
    terminated; "Company decision to discontinue trial"
  • NCT02738008
    terminated; "Company decision to discontinue trial"
  • NCT02797522
    terminated; "Company decision to discontinue trial"
  • NCT03032536
    terminated; "Sponsor decision."
  • NCT03887702
    terminated; "inability to accrue"

recorded 2026-09-01 · last checked 2026-09-04

Human studies of Tenofovir Anhydrous used Tenofovir 1% vaginal gel — over how long?


Human studies of Tenofovir Anhydrous used "Tenofovir 1% vaginal gel". ClinicalTrials.gov · 2026-09-01

20 recorded entries; human; vaginal, oral; also "Tenofovir disoproxil fumarate (TDF) 300 mg", "FDC Emtricitabine 200 mg/ tenofovir 300 mg", "FDC Emtricitabine 200mg/Tenofovir 300mg DF/Efavirenz 600mg"

Show the evidence

human

  • NCT00705679
    vaginal; Tenofovir 1% vaginal gel
  • NCT00896051
    Tenofovir disoproxil fumarate (TDF) 300 mg
  • NCT00924898
    FDC Emtricitabine 200 mg/ tenofovir 300 mg
  • NCT00924898
    FDC Emtricitabine 200mg/Tenofovir 300mg DF/Efavirenz 600mg
  • NCT01384734
    Tenofovir 300 mg
  • NCT01448616
    Tenofovir 1% Vaginal Gel
14 more recorded rows
  • human NCT01937806
    tenofovir 300mg
  • human NCT02093585
    tenofovir (245 mg QD)
  • human NCT02792088
    Tenofovir 300mg
  • human NCT02805738
    Tenofovir disoproxil aspartate 308.04mg
  • human NCT02805738
    Tenofovir disoproxil fumarate 300mg
  • human NCT03360682
    Tenofovir Disoproxil 245Mg Tablet
  • human NCT03566030
    Tenofovir Alafenamide 25 mg
  • human NCT03917420
    Tenofovir 300Mg Oral Tablet
  • human NCT04237376
    Tenofovir Alafenamide 25 MG
  • human NCT04237376
    Tenofovir Disoproxil Fumarate 300 MG Oral Tablet
  • human NCT04302896
    oral; emtricitabine/tenofovir alafenamide oral tablet 200mg/25mg
  • human NCT04302896
    oral; tenofovir disoproxil fumarate oral tablet 300mg
  • human NCT04650828
    Tenofovir Disoproxil Fumarate 300 MG
  • human NCT04781426
    Tenofovir Disoproxil Fumarate (TDF) 300 mg

recorded 2026-09-01 · last checked 2026-09-04

Which running trial of Tenofovir Anhydrous could settle lifespan?


NCT03920618 measures Survival rate in the follow-up, reading out 2024-12-31.

1 open trial; n 150; "Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF"

Show the evidence
  • Trial NCT03920618
    "Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF"; n 150; "Survival rate in the follow-up"; 2024-12-31

Which 105 trials of Tenofovir Anhydrous posted no result?


Posted no result
105 of 105 completed trials
Registrations
NCT00044577, NCT00038506, NCT00053638, NCT00270556, NCT00033163 and NCT00027339, and 99 more
Completion dates
oldest 2004-05-25; newest 2024-06-26
Show the evidence

Trial

  • NCT00044577
    2004-05-25
  • NCT00038506
    2004-08
  • NCT00053638
    2004-10
  • NCT00270556
    2004-10
  • NCT00033163
    2005-05
  • NCT00027339
    2005-06
14 further recorded trials
  • NCT00028366
    2005-07
  • NCT00028132
    2005-12
  • NCT00050895
    2006-03
  • NCT00122486
    2006-03
  • NCT00034086
    2006-06
  • NCT00127959
    2006-08
  • NCT00344981
    2006-11
  • NCT00158457
    2006-12
  • NCT00100581
    2007-01
  • NCT00192595
    2007-01
  • NCT00102206
    2007-05
  • NCT00109603
    2007-11
  • NCT00192660
    2007-12
  • NCT00648817
    2007-12

At the median, Tenofovir Anhydrous's trials enrolled 88 people — anything larger?


Median enrolment
88
Largest enrolment
7350
Registered trials counted
275

What do 5764 spontaneous reports say about Tenofovir Anhydrous — and not say?


These are reports people sent to a regulator. They do not show the medicine caused the reaction. Nobody counted how many people took the medicine and reported nothing. The same event can be reported more than once, and many reports are incomplete. News coverage, lawsuits and new warnings change how often people report. A count is not a rate and not a risk.

Tenofovir Anhydrous appears in spontaneous reports to regulators. Across the 10 most-reported reaction terms, 5764 reaction mentions were counted: virologic failure 857; drug resistance 847; abortion spontaneous 615; osteoporosis 568. FAERS via Open Targets · CHEMBL3989702 · 2026-06-24

Show the evidence
  • virologic failure
    857
  • drug resistance
    847
  • abortion spontaneous
    615
  • osteoporosis
    568
  • blood creatinine increased
    547
  • pathogen resistance
    524
4 more recorded rows
  • viral mutation identified
    513
  • renal failure
    454
  • renal failure acute
    423
  • immune reconstitution inflammatory syndrome
    416

recorded 2026-06-24 · last checked 2026-09-04

Where it is registered
Identifiers, relations and other names

The exact record

ChEMBL id
CHEMBL3989702
PubChem CID
21146529
CAS number
206184-49-8
RxCUI
117466
InChIKey
SGOIRFVFHAKUTI-ZCFIWIBFSA-N
Also called
Tenofovir
Development code
GS-1278, PMP-A, PMPA, GS-1275
Salt form
Tenofovir hydrate, Tenofovir monohydrate, tenofovir disoproxil fumarate, tfv gel
Also called
emtricitabine/tenofovir, tdf, tenofovir df, tenofovir disoproxil, tenofovir/emtricitabine, tfv, viread, TENOFOVIR [MART.], TENOFOVIR [USAN], TENOFOVIR [USP-RS], TENOFOVIR [VANDF], [[(R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phosphonic acid, monohydrate
Component
Tenofovir
Sources (5)

Sources

ClinicalTrials.gov — US Government work · Open Targets 26.06 — CC0 · mixed register set; per-register licences in docs/specs/corpus-20k-sources.md

How these records are assembled · Which registers were checked

Index-quality checks
  • identity passed: no open identity hold
  • required summary fields resolved: 3 required field(s) not terminal: Best-supported result, Biggest unanswered question, Human evidence
  • public claims reviewed: 0 reviewed claim(s); drafts are never rendered
  • source coverage passed: 5 source rows
  • no critical contamination: no quarantine open
  • canonical metadata passed: slug and display name present
  • no raw internal fields: enforced by the copy-contract test over the rendered page

This is a record of evidence. It is not medical advice, and it does not say this substance suits you. Nothing here says any substance on RNAWiki is appropriate for a child.